Quantum BioPharma Ltd. Deferred Tax Expense Income
Quantum BioPharma Ltd. (QNTM) reported Deferred Tax Expense Income of $0 for the 12-month period ending 2023-12-31, per its 20-F filed 2024-04-02.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:DeferredTaxExpenseIncome · last filed 2024-04-02
CAD
| Period end | Deferred Tax Expense Income 12 month |
|---|---|
| 2019-12-31 | 0.00 CAD 40-F/A · filed 2020-03-17 |
| 2018-12-31 | 0.00 CAD 40-F/A · filed 2020-03-17 |
USD
| Period end | Deferred Tax Expense Income 12 month |
|---|---|
| 2023-12-31 | $0.00 20-F · filed 2024-04-02 |
| 2022-12-31 | $0.00 20-F · filed 2024-04-02 |
| 2021-12-31 | $0.00 20-F · filed 2024-04-02 |
| 2020-12-31 | $0.00 40-F · filed 2021-03-17 |
| 2019-12-31 | $0.00 20-F · filed 2023-03-31 |